These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 19068246)

  • 61. Chain-reaction Ca(2+) signaling in the heart.
    Györke S; Hagen BM; Terentyev D; Lederer WJ
    J Clin Invest; 2007 Jul; 117(7):1758-62. PubMed ID: 17607353
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
    Priori SG; Napolitano C; Memmi M; Colombi B; Drago F; Gasparini M; DeSimone L; Coltorti F; Bloise R; Keegan R; Cruz Filho FE; Vignati G; Benatar A; DeLogu A
    Circulation; 2002 Jul; 106(1):69-74. PubMed ID: 12093772
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice.
    Chopra N; Kannankeril PJ; Yang T; Hlaing T; Holinstat I; Ettensohn K; Pfeifer K; Akin B; Jones LR; Franzini-Armstrong C; Knollmann BC
    Circ Res; 2007 Sep; 101(6):617-26. PubMed ID: 17656677
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Accentuated vagal antagonism paradoxically increases ryanodine receptor calcium leak in long-term exercised Calsequestrin2 knockout mice.
    Ho HT; Thambidorai S; Knollmann BC; Billman GE; Györke S; Kalyanasundaram A
    Heart Rhythm; 2018 Mar; 15(3):430-441. PubMed ID: 29030236
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular basis of catecholaminergic polymorphic ventricular tachycardia.
    Györke S
    Heart Rhythm; 2009 Jan; 6(1):123-9. PubMed ID: 19121813
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.
    Sy RW; Gollob MH; Klein GJ; Yee R; Skanes AC; Gula LJ; Leong-Sit P; Gow RM; Green MS; Birnie DH; Krahn AD
    Heart Rhythm; 2011 Jun; 8(6):864-71. PubMed ID: 21315846
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular diagnostics of catecholaminergic polymorphic ventricular tachycardia using denaturing high-performance liquid chromatography and sequencing.
    Postma AV; Bhuiyan ZA; Bikker H
    Methods Mol Med; 2006; 126():171-83. PubMed ID: 16930012
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Calsequestrin mutation and catecholaminergic polymorphic ventricular tachycardia: a simulation study of cellular mechanism.
    Faber GM; Rudy Y
    Cardiovasc Res; 2007 Jul; 75(1):79-88. PubMed ID: 17531962
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Targeting intracellular calcium cycling in catecholaminergic polymorphic ventricular tachycardia: a theoretical investigation.
    Sung RJ; Lo CP; Hsiao PY; Tien HC
    Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1625-38. PubMed ID: 21742998
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Channel Activity of Cardiac Ryanodine Receptors (RyR2) Determines Potency and Efficacy of Flecainide and R-Propafenone against Arrhythmogenic Calcium Waves in Ventricular Cardiomyocytes.
    Savio-Galimberti E; Knollmann BC
    PLoS One; 2015; 10(6):e0131179. PubMed ID: 26121139
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients.
    Faggioni M; Hwang HS; van der Werf C; Nederend I; Kannankeril PJ; Wilde AA; Knollmann BC
    Circ Res; 2013 Feb; 112(4):689-97. PubMed ID: 23295832
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Viral gene transfer rescues arrhythmogenic phenotype and ultrastructural abnormalities in adult calsequestrin-null mice with inherited arrhythmias.
    Denegri M; Avelino-Cruz JE; Boncompagni S; De Simone SA; Auricchio A; Villani L; Volpe P; Protasi F; Napolitano C; Priori SG
    Circ Res; 2012 Mar; 110(5):663-8. PubMed ID: 22298808
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Purkinje cell calcium dysregulation is the cellular mechanism that underlies catecholaminergic polymorphic ventricular tachycardia.
    Herron TJ; Milstein ML; Anumonwo J; Priori SG; Jalife J
    Heart Rhythm; 2010 Aug; 7(8):1122-8. PubMed ID: 20538074
    [TBL] [Abstract][Full Text] [Related]  

  • 74. RYR2 and CASQ2 mutations in patients suffering from catecholaminergic polymorphic ventricular tachycardia.
    Lahat H; Pras E; Eldar M
    Circulation; 2003 Jan; 107(3):e29; author reply e29. PubMed ID: 12551888
    [No Abstract]   [Full Text] [Related]  

  • 75. The cardiac ryanodine receptor (RyR2) and its role in heart disease.
    Taur Y; Frishman WH
    Cardiol Rev; 2005; 13(3):142-6. PubMed ID: 15831148
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction.
    Ohno S; Omura M; Kawamura M; Kimura H; Itoh H; Makiyama T; Ushinohama H; Makita N; Horie M
    Europace; 2014 Nov; 16(11):1646-54. PubMed ID: 24394973
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2.
    Maizels L; Huber I; Arbel G; Tijsen AJ; Gepstein A; Khoury A; Gepstein L
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28630169
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.
    Viatchenko-Karpinski S; Terentyev D; Györke I; Terentyeva R; Volpe P; Priori SG; Napolitano C; Nori A; Williams SC; Györke S
    Circ Res; 2004 Mar; 94(4):471-7. PubMed ID: 14715535
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The phenotype of a CASQ2 mutation in a Saudi family with catecholaminergic polymorphic ventricular tachycardia.
    Al-Hassnan ZN; Tulbah S; Al-Manea W; Al-Fayyadh M
    Pacing Clin Electrophysiol; 2013 May; 36(5):e140-2. PubMed ID: 22650415
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Catecholaminergic polymorphic ventricular tachycardia.
    Francis J; Sankar V; Nair VK; Priori SG
    Heart Rhythm; 2005 May; 2(5):550-4. PubMed ID: 15840485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.